![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
P Fan
Laboratory of Molecular and Cellular Neurobiology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892.
The effect of morphine on the ion current mediated by 5- hydroxytryptamine (5-HT3) receptors was investigated in rat nodose ganglion neurons and in Xenopus oocytes expressing the cloned 5-HT3 receptor. Morphine reversibly inhibited the 5-HT-induced current and shifted the 5-HT concentration-response curve to the right in a parallel fashion, without reducing the maximal 5-HT response. IC50 values for morphine were 0.3 microM in nodose neurons and 0.32 microM in oocytes. The apparent Kd of morphine in nodose neurons was 0.903 microM. This effect of morphine was immediate not dependent on membrane potential, and not prevented by the opioid receptor antagonists naltrexone and beta-chlornaltrexamine. It is concluded that opioid receptors were not involved in the present study and that morphine acted at the agonist recognition site located on the 5-HT3 receptor.
This article has been cited by other articles:
|
|
 |
|
  M.-P. Bonnet, E. Marret, J. Josserand, and F. J. Mercier Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review Br. J. Anaesth., September 1, 2008; 101(3): 311 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wittmann, T. Schaaf, I. Peters, S. Wirz, B. W. Urban, and M. Barann The Effects of Fentanyl-Like Opioids and Hydromorphone on Human 5-HT3A Receptors Anesth. Analg., July 1, 2008; 107(1): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wittmann, I. Peters, T. Schaaf, H. C. Wartenberg, S. Wirz, J. Nadstawek, B. W. Urban, and M. Barann The Effects of Morphine on Human 5-HT3A Receptors. Anesth. Analg., September 1, 2006; 103(3): 747 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Iatrou, C. K. Dragoumanis, T. D. Vogiatzaki, G. I. Vretzakis, C. E. Simopoulos, and V. K. Dimitriou Prophylactic Intravenous Ondansetron and Dolasetron in Intrathecal Morphine-Induced Pruritus: A Randomized, Double-Blinded, Placebo-Controlled Study Anesth. Analg., November 1, 2005; 101(5): 1516 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Charuluxananan, O. Kyokong, W. Somboonviboon, A. Narasethakamol, and P. Promlok Nalbuphine Versus Ondansetron for Prevention of Intrathecal Morphine-Induced Pruritus After Cesarean Delivery Anesth. Analg., June 1, 2003; 96(6): 1789 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Gurkan and K. Toker Prophylactic Ondansetron Reduces the Incidence of Intrathecal Fentanyl-Induced Pruritus Anesth. Analg., December 1, 2002; 95(6): 1763 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-M. Yeh, L.-K. Chen, C.-J. Lin, W.-H. Chan, Y.-P. Chen, C.-S. Lin, W.-Z. Sun, M.-J. Wang, and S.-K. Tsai Prophylactic Intravenous Ondansetron Reduces the Incidence of Intrathecal Morphine-Induced Pruritus in Patients Undergoing Cesarean Delivery Anesth. Analg., July 1, 2000; 91(1): 172 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Coultrap, H. Sun, T. E. Tenner Jr., and T. K. Machu Competitive Antagonism of the Mouse 5-Hydroxytryptamine3 Receptor by Bisindolylmaleimide I, a "Selective" Protein Kinase C Inhibitor J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 76 - 82. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
